People with immune thrombocytopenia (ITP) who have had their spleens surgically removed may face an increased risk of clotting…
Articles by Marisa Wexler MS
Adding Cyklokapron (tranexamic acid) to Vonvendi (recombinant von Willebrand factor) does not appear to reduce blood loss following childbirth for…
Casi Pharmaceuticals has been given the all-clear to start dosing a fifth group of patients in a clinical trial…
The U.S. Food and Drug Administration (FDA) has expanded its approval of Vonvendi (recombinant von Willebrand factor), a treatment for…
Using both corticosteroids and plasma exchange therapy — each a standard treatment for acquired thrombotic thrombocytopenic purpura (TTP) —…
The congenital form of thrombotic thrombocytopenic purpura (TTP) can look very different in one person than in another, but…
Daratumumab, an injection therapy approved to treat myeloma, may help to control immune thrombocytopenia (ITP) in individuals whose disease…
A Phase 3 clinical trial testing ianalumab (VAY736) in combination with Promacta (eltrombopag) in people with primary immune thrombocytopenia…
Increasing the use of Haemate-P to treat von Willebrand disease (VWD) could yield substantial savings for the healthcare system…
People with von Willebrand disease (VWD) or hemophilia may experience bleeding complications after dental procedures, a new study highlights.